Renal Business Today - dialysis, end-stage renal disease (ESRD), home dialysis, chronic kidney disease (CKD), nephrology, Medicare bundle, kidney, dialysis practice management, kidney disease patients

FEATURES

Essay Contest for Kidney Patients

GLENDALE, Calif.—The Renal Support Network (RSN), a nonprofit, patient-focused, patient-run organization that provides nonmedical services to those affected by chronic kidney disease (CKD), encourages people with kidney ...read more

Travel on Dialysis

“The world is a book, and those who do not travel read only one page,” said Augustine of Hippo. For many, travel provides an expanded world view and a great deal of joy. For many hemodialysis patients, travel seems ...read more

2013 RPA Meeting

If you missed the three-day, 2013 Renal Physician Association conference held in New Orleans, Renal Business Today was there and has the highlights available at your fingertips in the latest digital issue. Renal ...read more

Venous Needle Dislodgement

Venous needle dislodgement (VND) occurs when a venous needle dislodges from a patient's vascular access during hemodialysis treatment. This report discusses VND severity and presents best practices and other solutions to ...read more

A Recipe Guide to Lowering Salt Intake

Whether you are a kidney disease patient or a non-kidney patient, it is important to keep your kidneys as healthy as possible by following a low-sodium diet. Did you know that for a healthy individual over the age of 50, a ...read more

Latest Headlines

AnorMED gets $3 million milestone payment for Fosrenol

VANCOUVER--AnorMED Inc. will receive a $3-million milestone payment from Shire Pharmaceuticals after the phosphorus drug Fosrenol obtained licensing approval in Germany. ...More
September 18, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation
Ex-Renal Care executive Brukardt leaves Fresenius

NASHVILLE--Gary Brukardt, who was the former chief executive of Renal Care Group, has left his current position as an executive with Fresenius Medical Care, according to a recent news report. ...More
September 18, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation
Epogen, dialysis industry set for public trial

The diligence at which Amgen defends its erythropoietin (EPO) patents is like a mother bear ferociously attacking any possible threat to her cubs. In this case, Amgen's cubs are worth billions of dollars. Yet, for all the grief Amgen has received in the media for its ...More
September 14, 2006
Posted in Blog
Many nephrologists unprepared for end-of-life decisions

WASHINGTON--Sixty percent of nephrologists don't feel well prepared to make the decision to stop dialysis in kidney disease patients nearing the end of life, according to a study in November's Clinical Journal of the American Society of Nephrology. ...More
September 14, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
Is NxStage reaching a tipping point?

If you're going to take on a paradigm or introduce a new product, the change isn't going to happen overnight. But a good strategy can go a long way, especially when the odds are stacked against you. NxStage finds itself in this precarious situation. It has a relatively new ...More
September 13, 2006
Posted in Blog
Judge fast-tracks Amgen, Roche patent suit

BOSTON-- A federal judge decided this week to grant an accelerated hearing for Amgen's anemia-drug patent case against Roche--a week after the U.S. International Trade Commission dropped its investigation into Roche's alleged infringement. ...More
September 13, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation
Diplomat Specialty Pharma starts CKD disease management programs

FLINT, Mich.--Diplomat Specialty Pharmacy said earlier this week that the company's Chronic Kidney Disease Management Division has started two pilot programs in Michigan. ...More
September 8, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
RenaMed locks up $40 million in private equity financing

WESTBOROUGH, Mass.--RenaMed Biologics Inc. said today it has finalized a deal that will give the company $40 million in private equity financing. ...More
September 7, 2006
Posted in News, Business, Clinical & Pharma
Amgen launches new Aranesp injection device for CKD patients

THOUSAND OAKS, Calif.--Amgen Inc. said Thursday it has launched the Aranesp prefilled SureClick autoinjector to treat anemia in patients with chronic kidney disease and patients undergoing chemotherapy. ...More
September 7, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
Hospital-based administrators need to get involved

It's important for any professional to network with colleagues and stay in tune with shifting industry trends. Doctors have moved on from a shot of whiskey and a stick to bite to subdue patient pain, and, likewise, dialysis clinic administrators shouldn't operate in the ...More
September 5, 2006
Posted in Blog